Menzies-Gow, Andrew
Chiu, Gavin
Article History
Received: 15 February 2017
Revised: 11 July 2017
Accepted: 18 July 2017
First Online: 11 August 2017
Competing interests
: AMG has attended advisory boards (Astra Zeneca, Boehringer Ingelheim, Glaxo SmithKline, Novartis, Teva & Roche); international conferences with Napp & Boehringer Ingelheim UK; and received lecture fees from Boehringer Ingelheim UK, Astra Zeneca, Glaxo SmithKline, Novartis, Teva, Roche and Napp. GC is employed by Boehringer Ingelheim UK.